Stimulating Hematology Investigation: New Endeavors (SHINE)
Funds basic and early translational research on non-cancerous blood disorders, in topics three institutes refresh every year.
Haematology research money follows leukaemia and lymphoma. This programme exists for everything else in blood — sickle cell disease, clotting and bleeding disorders, anaemias, marrow failure, iron biology.
Three institutes run it together: diabetes and digestive and kidney diseases; aging; and heart, lung and blood. The work has to be relevant to at least one of those missions, and the stated aim…
Investigator-initiated basic and early translational research in non-malignant haematology relevant to the missions of the diabetes and digestive and kidney diseases, aging, and heart, lung and blood institutes, in specific emerging topics that are updated annually through a linked notice. Clinical trials are not allowed.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up